Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Laisné
Php301 - The Time Is Now for European Hta: How Will the Evolution of European Hta Impact Access to Innovative Medicines?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcp23 - Does the European Union (Eu) Need European Hta or European Procurement?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn275 - How Do Hta Decisions for New Disease Conditions Impact Time to Price Changes?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php192 - Hta Educational Needs in Central-Eastern-South European (Cese) Countires – Results of Joc Hta Project
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php31 - Impact of European Medicines Agency (Ema) Clinical Trial Transparency Policies on Health Technology Assessment (Hta) Decisions in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php284 - Time to Hta Decision for Internationalised Medicines in Australia, Canada and Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Access to Medicines and European Market Integration
SSRN Electronic Journal
Access to New Therapies in Romania Through the Scorecard HTA System
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
What Is the European Medicines Agency?
Epidemiology and Psychiatric Sciences
Mental Health
Epidemiology
Public Health
Environmental
Psychiatry
Occupational Health
Php281 - The Methodological Differences of European Joint Assessment and German Hta: An Empirical Approach
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental